Therapeutic effects of hydrogen in animal models of Parkinson's disease

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Fujita, Kyota ^a   Nakabeppu, Yusaku ^a   Noda, Mami ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; HYDROGEN; NEUROTOXIN; OXIDOPAMINE;

APOPTOSIS; DISEASE COURSE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; EXPERIMENTAL MODEL; NERVE CELL NECROSIS; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 80052695403     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/307875     Document Type: Review

References (93)

1. Dauer W., Przedborski S., Parkinson's disease: mechanisms and models Neuron 2003 39 6 889 909 (Pubitemid 37130207)
2. Glass C. K., Saijo K., Winner B., Marchetto M. C., Gage F. H., Mechanisms Underlying Inflammation in Neurodegeneration Cell 2010 140 6 918 934
3. Lang A. E., Lozano A. M., Parkinson's disease The New England Journal of Medicine 1998 339 15 1044 1053 (Pubitemid 28457867)
4. Ziering A., Berger L., Heineman S. D., Lee J., Piperidine derivatives. Part III. 4-arylpiperidines Journal of Organic Chemistry 1947 12 6 894 903
5. Przedborski S., Tieu K., Perier C., Vila M., MPTP as a mitochondrial neurotoxic model of Parkinson's disease Journal of Bioenergetics and Biomembranes 2004 36 4 375 379 (Pubitemid 39619844)
6. Blandini F., Armentero M. T., Martignoni E., The 6-hydroxydopamine model: news from the past Parkinsonism and Related Disorders 2008 14 2 S124 S129
7. Langston J. W., Irwin I., Langston E. B., Forno L. S., 1-Methyl-4-phenylpyridinium ion (MPP): identification of a metabolite of MPTP, a toxin selective to the substantia nigra Neuroscience Letters 1984 48 1 87 92 (Pubitemid 14084283)
8. Chiba K., Trevor A., Castagnoli N., Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase Biochemical and Biophysical Research Communications 1984 120 2 574 578 (Pubitemid 14101750)
9. Chiba K., Peterson L. A., Castagnoli K. P., Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Drug Metabolism and Disposition 1985 13 3 342 347 (Pubitemid 15009452)
10. Peterson L. A., Caldera P. S., Trevor A., Chiba K., Castagnoli N., Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium Species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Journal of Medicinal Chemistry 1985 28 10 1432 1436 (Pubitemid 16229730)
11. Javitch J. A., D'Amato R. J., Strittmatter S. M., Snyder S. H., Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proceedings of the National Academy of Sciences of the United States of America 1985 82 7 2173 2177 (Pubitemid 15056491)
12. Ramsay R. R., Dadgar J., Trevor A., Singer T. P., Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP Life Sciences 1986 39 7 581 588 (Pubitemid 16040078)
13. Ramsay R. R., Singer T. P., Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine, by mitochondria The Journal of Biological Chemistry 1986 261 17 7585 7587 (Pubitemid 17208669)
14. Nicklas W. J., Vyas I., Heikkila R. E., Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sciences 1985 36 26 2503 2508 (Pubitemid 15072756)
15. Mizuno Y., Sone N., Saitoh T., Effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain Journal of Neurochemistry 1987 48 6 1787 1793 (Pubitemid 17101550)
16. Chan P., DeLanney L. E., Irwin I., Langston J. W., Di Monte D., Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain Journal of Neurochemistry 1991 57 1 348 351
17. Davey G. P., Peuchen S., Clark J. B., Energy thresholds in brain mitochondria: potential involvement in neurodegeneration The Journal of Biological Chemistry 1998 273 21 12753 12757 (Pubitemid 28246828)
18. Jackson-Lewis V., Przedborski S., Protocol for the MPTP mouse model of Parkinson's disease Nature Protocols 2007 2 1 141 151 (Pubitemid 47044700)
19. Fujita K., Seike T., Yutsudo N., Ohno M., Yamada H., Yamaguchi H., Sakumi K., Yamakawa Y., Kido M. A., Takaki A., Katafuchi T., Tanaka Y., Nakabeppu Y., Noda M., Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease PLoS ONE 2009 4 9
20. Benner E. J., Banerjee R., Reynolds A. D., Sherman S., Pisarev V. M., Tsiperson V., Nemachek C., Ciborowski P., Przedborski S., Mosley R. L., Gendelman H. E., Nitrated -synuclein immunity accelerates degeneration of nigral dopaminergic neurons PLoS ONE 2008 3 1
21. Fornai F., Schlter O. M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., Lazzeri G., Busceti C. L., Pontarelli F., Battaglia G., Pellegrini A., Nicoletti F., Ruggieri S., Paparelli A., Sdhof T. C., Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and -synuclein Proceedings of the National Academy of Sciences of the United States of America 2005 102 9 3413 3418 (Pubitemid 40328059)
22. Song D. D., Haber S. N., Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting Journal of Neuroscience 2000 20 13 5102 5114 (Pubitemid 30421713)
23. Du X., Stull N. D., Iacovitti L., Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neurons Brain Research 1995 680 1-2 229 233
24. Greenamyre J. T., Dopaminergic neurons intrinsic to the primate striatum Journal of Neuroscience 1997 17 17 6761 6768 (Pubitemid 27366627)
25. Meredith G. E., Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions European Journal of Neuroscience 1999 11 10 3585 3596 (Pubitemid 29484255)
26. Marien M. R., Colpaert F. C., Rosenquist A. C., Noradrenergic mechanisms in neurodegenerative diseases: a theory Brain Research Reviews 2004 45 1 38 78 (Pubitemid 38520015)
27. Rommelfanger K. S., Edwards G. L., Freeman K. G., Liles L. C., Miller G. W., Weinshenker D., Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13804 13809 (Pubitemid 350003401)
28. Hasegawa E., Takeshige K., Oishi T., Murai Y., Minakami S., 1-Methyl-4-phenylpyridinium (MPP) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles Biochemical and Biophysical Research Communications 1990 170 3 1049 1055 (Pubitemid 20273373)
29. Fahre E., Monserrat J., Herrero A., Barja G., Leret M. L., Effect of MPTP on brain mitochondrial HO and ATP production and on dopamine and DOPAC in the striatum Journal of Physiology and Biochemistry 1999 55 4 325 332
30. Singer T. P., Ramsay R. R., McKeown K., Trevor A., Castagnoli N. E., Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Toxicology 1988 49 1 17 23
31. Gutteridge J. M. C., Iron and oxygen radicals in brain Annals of Neurology 1992 32 S16 S21
32. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P., Halliwell B., Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra Journal of Neurochemistry 1997 69 3 1196 1203 (Pubitemid 27364841)
33. Zhang J., Perry G., Smith M. A., Robertson D., Olson S. J., Graham D. G., Montine T. J., Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons American Journal of Pathology 1999 154 5 1423 1429 (Pubitemid 29226437)
34. Hirsch E. C., Hunot S., Neuroinflammation in Parkinson's disease: a target for neuroprotection? The Lancet Neurology 2009 8 4 382 397
35. Graham D. G., Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Molecular Pharmacology 1978 14 4 633 643 (Pubitemid 8402469)
36. Boada J., Cutillas B., Roig T., Bermdez J., Ambrosio S., MPP+ -induced mitochondrial dysfunction is potentiated by dopamine Biochemical and Biophysical Research Communications 2000 268 3 916 920 (Pubitemid 30150891)
37. Drukarch B., van Muiswinkel F. L., Neuroprotection for Parkinson's disease: a new approach for a new millennium Expert Opinion on Investigational Drugs 2001 10 10 1855 1868 (Pubitemid 32982810)
38. Mandavilli B. S., Ali S. F., Van Houten B., DNA damage in brain mitochondria caused by aging and MPTP treatment Brain Research 2000 885 1 45 52
39. Yamaguchi H., Kajitani K., Dan Y., Furuichi M., Ohno M., Sakumi K., Kang D., Nakabeppu Y., MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Cell Death and Differentiation 2006 13 4 551 563
40. Selley M. L., (E)-4-Hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease Free Radical Biology and Medicine 1998 25 2 169 174 (Pubitemid 28293150)
41. Liang L. I. P., Huang J., Fulton R., Day B. J., Patel M., An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity in vivo Journal of Neuroscience 2007 27 16 4326 4333 (Pubitemid 46640723)
42. Saporito M. S., Thomas B. A., Scott R. W., MPTP activates c-Jun NH-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo Journal of Neurochemistry 2000 75 3 1200 1208 (Pubitemid 30660510)
43. Karunakaran S., Saeed U., Mishra M., Valli R. K., Joshi S. D., Meka D. P., Seth P., Ravindranath V., Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice Journal of Neuroscience 2008 28 47 12500 12509
44. Karunakaran S., Ravindranath V., Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF- B in MPTP-treated mice: implication in Parkinson's disease Journal of Neurochemistry 2009 109 6 1791 1799
45. Vila M., Jackson-Lewis V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S. J., Przedborski S., Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2837 2842 (Pubitemid 32209570)
46. Kamiya H., Kasai H., Formation of 2-hydroxydeoxyadenosine triphosphate, an oxidatively damaged nucleotide, and its incorporation by DNA polymerases. Steady-state kinetics of the incorporation The Journal of Biological Chemistry 1995 270 33 19446 19450
47. Nakabeppu Y., Tsuchimoto D., Yamaguchi H., Sakumi K., Oxidative damage in nucleic acids and Parkinson's disease Journal of Neuroscience Research 2007 85 5 919 934 (Pubitemid 46580334)
48. Ohno M., Oka S., Nakabeppu Y., Quantitative analysis of oxidized guanine, 8-oxoguanine, in mitochondrial DNA by immunofluorescence method Methods in Molecular Biology 2009 554 199 212
49. Oka S., Ohno M., Tsuchimoto D., Sakumi K., Furuichi M., Nakabeppu Y., Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs The EMBO Journal 2008 27 2 421 432 (Pubitemid 351161663)
50. Michaels M. L., Tchou J., Grollman A. P., Miller J. H., A repair system for 8-oxo-7,8-dihydrodeoxyguanine Biochemistry 1992 31 45 10964 10968
51. Hirano S., Tominaga Y., Ichinoe A., Ushijima Y., Tsuchimoto D., Honda-Ohnishi Y., Ohtsubo T., Sakumi K., Nakabeppu Y., Mutator phenotype of MUTYH-null mouse embryonic stem cells The Journal of Biological Chemistry 2003 278 40 38121 38124 (Pubitemid 37221699)
52. Tominaga Y., Ushijima Y., Tsuchimoto D., Mishima M., Shirakawa M., Hirano S., Sakumi K., Nakabeppu Y., MUTYH prevents OGG1 or APEX1 from inappropriately processing its substrate or reaction product with its C-terminal domain Nucleic Acids Research 2004 32 10 3198 3211 (Pubitemid 39028860)
53. Michaels M. L., Tchou J., Grollman A. P., Miller J. H., A repair system for 8-oxo-7,8-dihydrodeoxyguanine Biochemistry 1992 31 45 10964 10968
54. Simbula G., Glascott P. A. Jr., Akita S., Hoek J. B., Farber J. L., Two mechanisms by which ATP depletion potentiates induction of the mitochondrial permeability transition American Journal of Physiology 1997 273 2 C479 C488
55. Vosler P. S., Brennan C. S., Chen J., Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration Molecular Neurobiology 2008 38 1 78 100
56. Crocker S. J., Smith P. D., Jackson-Lewis V., Lamba W. R., Hayley S. P., Grimm E., Callaghan S. M., Slack R. S., Melloni E., Przedborski S., Robertson G. S., Anisman H., Merali Z., Park D. S., Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease Journal of Neuroscience 2003 23 10 4081 4091 (Pubitemid 36958427)
57. Eki T., Hurwitz J., Influence of poly(ADP-ribose) polymerase on the enzymatic synthesis of SV40 DNA The Journal of Biological Chemistry 1991 266 5 3087 3100 (Pubitemid 21909178)
58. Soldani C., Scovassi A. I., Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update Apoptosis 2002 7 4 321 328 (Pubitemid 34832256)
59. Yu S. W., Wang H., Poitras M. F., Coombs C., Bowers W. J., Federoff H. J., Poirier G. G., Dawson T. M., Dawson V. L., Mediation of poty(ADP-ribose) polymerase-1dependent cell death by apoptosis-inducing factor Science 2002 297 5579 259 263 (Pubitemid 34761289)
60. Mandir A. S., Przedborski S., Jackson-Lewis V., Wang Z. Q., Simbulan-Rosenthal C. M., Smulson M. E., Hoffman B. E., Guastella D. B., Dawson V. L., Dawson T. M., Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism Proceedings of the National Academy of Sciences of the United States of America 1999 96 10 5774 5779 (Pubitemid 29234694)
61. Wang H., Shimoji M., Yu S. W., Dawson T. M., Dawson V. L., Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease Annals of the New York Academy of Sciences 2003 991 132 139 (Pubitemid 36793809)
62. Veto S., Acs P., Bauer J., Lassmann H., Berente Z., Setalo G., Borgulya G., Sumegi B., Komoly S., Gallyas F., Illes Z., Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death Brain 2010 133 3 822 834
63. Alano C. C., Ying W., Swanson R. A., Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD depletion and mitochondrial permeability transition The Journal of Biological Chemistry 2004 279 18 18895 18902 (Pubitemid 38623317)
64. Heikkila R., Cohen G., Inhibition of biogenic amine uptake by hydrogen peroxide: a mechanism for toxic effects of 6-hydroxydopamine Science 1971 172 3989 1257 1258
65. Cohen G., Heikkila R. E., The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6 hydroxydopamine, dialuric acid, and related cytotoxic agents The Journal of Biological Chemistry 1974 249 8 2447 2452
66. Blum D., Torch S., Lambeng N., Nissou M. F., Benabid A. L., Sadoul R., Verna J. M., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Progress in Neurobiology 2001 65 2 135 172 (Pubitemid 32524182)
67. Slivka A., Cohen G., Hydroxyl radical attack on dopamine The Journal of Biological Chemistry 1985 260 29 15466 15472 (Pubitemid 16170079)
68. Jellinger K., Linert L., Kienzl E., Herlinger E., Youdim M. B. H., Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease Journal of Neural Transmission, Supplement 1995 46 297 314 (Pubitemid 26043238)
69. Linert W., Herlinger E., Jameson R. F., Kienzl E., Jellinger K., Youdim M. B. H., Dopamine, 6-hydroxydopamine, iron, and dioxygentheir mutual interactions and possible implication in the development of Parkinson's disease Biochimica et Biophysica Acta 1996 1316 3 160 168 (Pubitemid 26273700)
70. Palumbo A., Napolitano A., Barone P., D'Ischia M., Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6- nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration Chemical Research in Toxicology 1999 12 12 1213 1222 (Pubitemid 30013532)
71. Garner C. D., Nachtman J. P., Manganese catalyzed auto-oxidation of dopamine to 6-hydroxydopamine in vitro Chemico-Biological Interactions 1989 69 4 345 351 (Pubitemid 19127807)
72. Breese G. R., Traylor T. D., Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine British Journal of Pharmacology 1971 42 1 88 99
73. Karoum F., Chrapusta S. J., Egan M. F., Wyatt R. J., Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study Journal of Neurochemistry 1993 61 4 1369 1375 (Pubitemid 23285095)
74. Kaminski Schierle G. S., Hansson O., Ferrando-May E., Nicotera P., Brundin P., Leist M., Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation NeuroReport 1999 10 16 3347 3351
75. van Muiswinkel F. L., Drukarch B., Steinbusch H. W. M., De Vente J., Sustained pharmacological inhibition of nitric oxide synthase does not affect the survival of intrastriatal rat fetal mesencephalic transplants Brain Research 1998 792 1 48 58 (Pubitemid 28261167)
76. Ohsawa I., Ishikawa M., Takahashi K., Watanabe M., Nishimaki K., Yamagata K., Katsura K. I., Katayama Y., Asoh S., Ohta S., Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals Nature Medicine 2007 13 6 688 694 (Pubitemid 46889750)
77. Nagata K., Nakashima-Kamimura N., Mikami T., Ohsawa I., Ohta S., Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice Neuropsychopharmacology 2009 34 2 501 508
78. Gu Y., Huang C. S., Inoue T., Yamashita T., Ishida T., Kang KI. M., Nakao A., Drinking hydrogen water ameliorated cognitive impairment in senescence-accelerated mice Journal of Clinical Biochemistry and Nutrition 2010 46 3 269 276
79. Fukuda K. I., Asoh S., Ishikawa M., Yamamoto Y., Ohsawa I., Ohta S., Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress Biochemical and Biophysical Research Communications 2007 361 3 670 674 (Pubitemid 47238041)
80. Buchholz B. M., Kaczorowski D. J., Sugimoto R., Yang R., Wang Y., Billiar T. R., McCurry K. R., Bauer A. J., Nakao A., Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury American Journal of Transplantation 2008 8 10 2015 2024
81. Nakao A., Kaczorowski D. J., Wang Y., Cardinal J. S., Buchholz B. M., Sugimoto R., Tobita K., Lee S., Toyoda Y., Billiar T. R., McCurry K. R., Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both Journal of Heart and Lung Transplantation 2010 29 5 544 553
82. Hayashida K., Sano M., Ohsawa I., Shinmura K., Tamaki K., Kimura K., Endo J., Katayama T., Kawamura A., Kohsaka S., Makino S., Ohta S., Ogawa S., Fukuda K., Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury Biochemical and Biophysical Research Communications 2008 373 1 30 35
83. Ohsawa I., Nishimaki K., Yamagata K., Ishikawa M., Ohta S., Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice Biochemical and Biophysical Research Communications 2008 377 4 1195 1198
84. Fu Y., Ito M., Fujita Y., Ito M., Ichihara M., Masuda A., Suzuki Y., Maesawa S., Kajita Y., Hirayama M., Ohsawa I., Ohta S., Ohno K., Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease Neuroscience Letters 2009 453 2 81 85
85. Stack E. C., Ferro J. L., Kim J., Del Signore S. J., Goodrich S., Matson S., Hunt B. B., Cormier K., Smith K., Matson W. R., Ryu H., Ferrante R. J., Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease Biochimica et Biophysica Acta 2008 1782 3 151 162
86. Setsukinai K. I., Urano Y., Kakinuma K., Majima H. J., Nagano T., Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species The Journal of Biological Chemistry 2003 278 5 3170 3175 (Pubitemid 36801227)
87. Sato Y., Kajiyama S., Amano A., Kondo Y., Sasaki T., Handa S., Takahashi R., Fukui M., Hasegawa G., Nakamura N., Fujinawa H., Mori T., Ohta M., Obayashi H., Maruyama N., Ishigami A., Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice Biochemical and Biophysical Research Communications 2008 375 3 346 350
88. Nakao A., Toyoda Y., Sharma P., Evans M., Guthrie N., Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndromean open label pilot study Journal of Clinical Biochemistry and Nutrition 2010 46 2 140 149
89. Alam J., Cook J. L., How many transcription factors does it take to turn on the heme oxygenase-1 gene? American Journal of Respiratory Cell and Molecular Biology 2007 36 2 166 174 (Pubitemid 46233469)
90. Dexter D. T., Wells F. R., Agid F., Agid Y., Lees A. J., Jenner P., Marsden C. D., Increased nigral iron content in postmortem Parkinsonian brain The Lancet 1987 2 8569 1219 1220 (Pubitemid 17156630)
91. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., Mizuno Y., Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease Proceedings of the National Academy of Sciences of the United States of America 1996 93 7 2696 2701 (Pubitemid 26114311)
92. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P., Halliwell B., A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease Journal of Neurochemistry 1997 69 3 1326 1329 (Pubitemid 27364859)
93. Shimura-Miura H., Hattori N., Kang D., Miyako K. I., Nakabeppu Y., Mizuno Y., Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease Annals of Neurology 1999 46 6 920 924.